Fluent Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-36,862
Closed -$4.09M 72
2025
Q3
$4.09M Sell
36,862
-3,286
-8% -$374K 1.6% 20
2025
Q2
$4.45M Buy
40,148
+14,326
+55% +$1.52M 1.83% 14
2025
Q1
$2.89M Sell
25,822
-3,334
-11% -$344K 1.26% 24
2024
Q4
$2.69M Buy
+29,156
New +$2.63M 1.19% 26

Other funds holding GILD

Fluent Financial's GILD Position: Q4 2025 in Review

Fluent Financial sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 36,862 shares — an estimated $4.09M sold.

Fluent Financial first reported a position in GILD in Q4 2024 and held it in 4 quarters. The position peaked at $4.45M in Q2 2025. 2,221 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Fluent Financial reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Fluent Financial sold 36,862 Gilead Sciences shares in Q4 2025, an estimated $4.09M.
  • Fluent Financial first reported a position in Gilead Sciences in Q4 2024 and held it in 4 quarters.
  • Fluent Financial's Gilead Sciences position peaked at $4.45M in Q2 2025.
  • 2,221 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Fluent Financial's 13F filing for Q4 2025, filed 14 Jan 2026.